Cabergoline Versus Calcium Gluconate Infusion in the Prevention of Ovarian Hyperstimulation Syndrome

NCT02875587 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

OHSS

Interventions

DRUG: Cabergoline
DRUG: Calcium gluconate

Sponsor

Aljazeera Hospital